Grant: Master's Award: Canada Graduate Scholarships
University of Calgary
$17,500.00
Investigating the increased severity of Clostridium difficile infection and Clostridium difficile toxin induced injury in Inflammatory Bowel Disease
FY 2010-11
Summary
Clostridium difficile (CD) is the leading cause of nosocomial infection diarrhea, and studies show that antibiotic-resistant, hyper virulent strains are spreading throughout the globe. This rapid increase in disease virulence is of particular importance to patients with Inflammatory Bowel Disease (IBD), who have been found to be four times more likely to die from Clostridium difficile infection (CDI), to have an increase in CD recurrence and morbidity, and to have higher rates of a severe outcome (requiring colectomy or leading to mortality). CDI can exasperate IBD leading to increased disease severity. Moreover, IBD is now an accepted risk factor for CDI, but the underlying reasons for their harsher clinical course are not well understood. Our lab has recently shown that the inflammasome, a component of the innate immune system, has a key role in the initiation of Clostridium difficile infection. Further, mice that are deficient in inflammasome components do not develop as severe CDI. In terms of IBD, our studies indicate that NLRP3 expression and activation is increased. Taken together, these results suggest that signaling through the NLRP3 inflammasome is key to the disease severity of CDI in IBD. We hypothesize that activation of the NLRP3 inflammasome signaling is responsible for the increased severity of CDI and Cdiff toxin-induced damage in IBD.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
225508
Name
Tulk Sarah E
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Investigating the increased severity of Clostridium difficile infection and Clostridium difficile toxin induced injury in Inflammatory Bowel Disease
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Clostridium Difficile; Cytokines; Infectious Colitis; Inflammasome; Inflammatory Bowel Disease; Inflammatory Signalling; Intestinal Inflammation
Abstract
Clostridium difficile (CD) is the leading cause of nosocomial infection diarrhea, and studies show that antibiotic-resistant, hyper virulent strains are spreading throughout the globe. This rapid increase in disease virulence is of particular importance to patients with Inflammatory Bowel Disease (IBD), who have been found to be four times more likely to die from Clostridium difficile infection (CDI), to have an increase in CD recurrence and morbidity, and to have higher rates of a severe outcome (requiring colectomy or leading to mortality). CDI can exasperate IBD leading to increased disease severity. Moreover, IBD is now an accepted risk factor for CDI, but the underlying reasons for their harsher clinical course are not well understood. Our lab has recently shown that the inflammasome, a component of the innate immune system, has a key role in the initiation of Clostridium difficile infection. Further, mice that are deficient in inflammasome components do not develop as severe CDI. In terms of IBD, our studies indicate that NLRP3 expression and activation is increased. Taken together, these results suggest that signaling through the NLRP3 inflammasome is key to the disease severity of CDI in IBD. We hypothesize that activation of the NLRP3 inflammasome signaling is responsible for the increased severity of CDI and Cdiff toxin-induced damage in IBD.
Competitiondate
201102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tulk, Sarah E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~